Joshua Margolis Named to Advisory Board

Novālent Biotech, Inc (‘Novālent’), a U.S. biotechnology engineering firm, is pleased to announce the appointment of renowned Harvard Business School Professor Joshua D. Margolis to our advisory board.

Professor Margolis is the James Dinan and Elizabeth Miller Professor of Business Administration at the Harvard Business School, where he is the Unit Head for the Organizational Behavior Unit and Faculty Chair of the Program for Leadership Development.

Professor Margolis’s research and teaching focuses on leadership and organizational effectiveness, and in particular, on equipping emerging leaders to do the work of leading organizations with ingenuity and integrity.

We are delighted to welcome Professor Margolis to our advisory board and look forward to making further announcements on this front in due course.


About Novalent

Novālent ® is a leading US biotechnology engineering firm which has pioneered the development of long-lasting technology to protect surfaces against stain and odor causing microorganisms.  Novalent® technology is based on a patented, non-toxic monomolecular layer that continuously inhibits the growth of stain and odor causing bacteria for up to 90 days on surfaces Used by leading US firms including PepsiCo, Pilgrims and HanesBrands, Novalent is private equity backed and is headquartered in Greensboro, North Carolina, with sales offices around the world. For more information on Novalent, visit